These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32581261)

  • 101. Emerging role for interferons in respiratory viral infections and childhood asthma.
    Bosco A
    Front Immunol; 2023; 14():1109001. PubMed ID: 36895568
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Bronchial epithelia from adults and children: SARS-CoV-2 spread via syncytia formation and type III interferon infectivity restriction.
    Beucher G; Blondot ML; Celle A; Pied N; Recordon-Pinson P; Esteves P; Faure M; Métifiot M; Lacomme S; Dacheux D; Robinson DR; Längst G; Beaufils F; Lafon ME; Berger P; Landry M; Malvy D; Trian T; Andreola ML; Wodrich H
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2202370119. PubMed ID: 35749382
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Axin1: A novel scaffold protein joins the antiviral network of interferon.
    Guo Y; Bamunuarachchi G; Vaddadi K; Zhu Z; Gandikota C; Ahmed K; Pushparaj S; More S; Xiao X; Yang X; Liang Y; Mukherjee S; Baviskar P; Huang C; Li S; Oomens AGP; Metcalf JP; Liu L
    Mol Microbiol; 2022 Dec; 118(6):731-743. PubMed ID: 36308071
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Type III Interferons in Antiviral Defenses at Barrier Surfaces.
    Wells AI; Coyne CB
    Trends Immunol; 2018 Oct; 39(10):848-858. PubMed ID: 30219309
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion.
    Broggi A; Granucci F; Zanoni I
    J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31821443
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Current Landscape of IFN-λ: Induction, Inhibition, and Potential Clinical Applications to Treat Respiratory Viral Infections.
    Martínez-Espinoza I; Guerrero-Plata A
    Immunohorizons; 2023 Apr; 7(4):265-272. PubMed ID: 37071039
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Editorial: Type I and Type III Interferon Immune Responses in Asthma.
    Finotto S; Jartti T; Johnston SL
    Front Immunol; 2021; 12():826363. PubMed ID: 35116044
    [No Abstract]   [Full Text] [Related]  

  • 108. Interferon-based agents for current and future viral respiratory infections: A scoping literature review of human studies.
    Mesic A; Jackson EK; Lalika M; Koelle DM; Patel RC
    PLOS Glob Public Health; 2022; 2(4):e0000231. PubMed ID: 36962150
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection.
    Habibi MS; Thwaites RS; Chang M; Jozwik A; Paras A; Kirsebom F; Varese A; Owen A; Cuthbertson L; James P; Tunstall T; Nickle D; Hansel TT; Moffatt MF; Johansson C; Chiu C; Openshaw PJM
    Science; 2020 Oct; 370(6513):. PubMed ID: 33033192
    [TBL] [Abstract][Full Text] [Related]  

  • 110. RSV and HMPV Infections in 3D Tissue Cultures: Mechanisms Involved in Virus-Host and Virus-Virus Interactions.
    Geiser J; Boivin G; Huang S; Constant S; Kaiser L; Tapparel C; Essaidi-Laziosi M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33478119
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Viral interference and interferon.
    Dianzani F
    Ric Clin Lab; 1975; 5(3):196-213. PubMed ID: 778995
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study.
    Wu A; Mihaylova VT; Landry ML; Foxman EF
    Lancet Microbe; 2020 Oct; 1(6):e254-e262. PubMed ID: 33103132
    [TBL] [Abstract][Full Text] [Related]  

  • 113. ORMDL3 regulates poly I:C induced inflammatory responses in airway epithelial cells.
    Laura G; Liu Y; Fernandes K; Willis-Owen SAG; Ito K; Cookson WO; Moffatt MF; Zhang Y
    BMC Pulm Med; 2021 May; 21(1):167. PubMed ID: 34001091
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Inhibition of SARS-CoV-2 by type I and type III interferons.
    Felgenhauer U; Schoen A; Gad HH; Hartmann R; Schaubmar AR; Failing K; Drosten C; Weber F
    J Biol Chem; 2020 Oct; 295(41):13958-13964. PubMed ID: 32587093
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The impact of the COVID-19 pandemic on respiratory failure caused by respiratory viruses in children and adolescents.
    Gama TB; Ferraro AA; Vieira SE
    Front Pediatr; 2024; 12():1392426. PubMed ID: 39210982
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Influence of non-pharmaceutical interventions on epidemiological characteristics of
    Jiang M; Zhang H; Yao F; Lu Q; Sun Q; Liu Z; Li Q; Wu G
    Front Microbiol; 2024; 15():1405710. PubMed ID: 39086655
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses.
    Gilbert-Girard S; Piret J; Carbonneau J; Hénaut M; Goyette N; Boivin G
    PLoS Pathog; 2024 Jul; 20(7):e1012017. PubMed ID: 39038029
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Unravelling the acute respiratory infection landscape: virus type, viral load, health status and coinfection do matter.
    Petat H; Corbet S; Leterrier B; Vabret A; Ar Gouilh M
    Front Cell Infect Microbiol; 2024; 14():1380855. PubMed ID: 38803572
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Co-Infections and Superinfections between HIV-1 and Other Human Viruses at the Cellular Level.
    Acchioni C; Sandini S; Acchioni M; Sgarbanti M
    Pathogens; 2024 Apr; 13(5):. PubMed ID: 38787201
    [TBL] [Abstract][Full Text] [Related]  

  • 120. IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection.
    Sojati J; Parks OB; Zhang Y; Walters S; Lan J; Eddens T; Lou D; Fan L; Chen K; Oury TD; Williams JV
    mBio; 2024 May; 15(5):e0055024. PubMed ID: 38530032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.